Prospects for Minimal Residual Disease as a Surrogate Endpoint in Pediatric Acute Lymphoblastic Leukemia Clinical Trials

Lignende værker

• Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia
  af: Galimberti, Stefania, et al.
  Udgivet: (2018)
• ROLE OF MINIMAL RESIDUAL DISEASE MONITORING IN ADULT AND PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
  af: Campana, Dario
  Udgivet: (2009)
• MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC LEUKEMIA
  af: Campana, Dario
  Udgivet: (2009)
• Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease
  af: M. A. Shervashidze, et al.
  Udgivet: (2020-10-01)
• Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease
  af: M. A. Shervashidze, et al.
  Udgivet: (2020-10-01)